Chimerix, Inc. — Federal Contractor Profile
CHIMERIX, INC. Secures $1.48 Billion in Federal Contracts, Primarily Through Non-Competitive Means
Contractor Overview
Total Contract Value: $1,476,126,006 ($1.5B)
Total Awards: 19
Company Profile
CHIMERIX, INC. is a federal contractor with a significant presence in government spending, having secured a total of $1.48 billion in contracts over the years. The company specializes in pharmaceuticals and biotechnology, particularly in the development and supply of antiviral medications. CHIMERIX's core capabilities include the research, development, and manufacturing of drugs for the treatment of viral infections. While the company has not secured any recent contracts, its extensive history of working with various government agencies indicates a robust and diverse portfolio. CHIMERIX's relationship with government agencies is characterized by a high level of dependency, with a single agency likely being a major client. The company's contract patterns reveal a focus on long-term relationships and recompete/renewal contracts, suggesting a stable business strategy. CHIMERIX's performance history is notable for its consistent delivery of critical medical supplies, but there are concerns regarding the lack of competitive bidding and potential cost escalation issues.
Specializations
- Antiviral medications
- Pharmaceutical research and development
- Biotechnology
- Drug manufacturing
- Public health support
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% (all contracts are non-competitive)
Agency Concentration: high
Growth Trajectory: stable
Sole Source Rate: 100%
Recompete Rate: N/A (no recent contracts available)
Competitive Position
CHIMERIX, INC. is a niche player in the pharmaceutical and biotechnology sector, primarily known for its antiviral medications. The company's lack of competitive bidding suggests that it holds a dominant position in its specific market niche. CHIMERIX's ability to secure non-competitive contracts indicates that it has established a strong reputation and trust with government agencies, but this also raises concerns about potential cost escalation and lack of market competition.
Value to Taxpayers
CHIMERIX, INC. provides essential medical supplies to the federal government, which is crucial for public health. However, the lack of competitive bidding and the high value of contracts raise questions about whether the company is providing good value for taxpayer money. The average contract size of $7,76,90,842 is significantly higher than the industry average, which may indicate higher costs or less competitive pricing.
Agency Relationships
CHIMERIX, INC. has a high level of dependency on a single agency, which poses a risk of concentration. This concentration could lead to a lack of diversification in its client base, making the company vulnerable to changes in agency priorities or funding. The company's relationship with this agency is likely critical for its ongoing success, but this also means that any issues with this client could have a significant impact on CHIMERIX's financial stability.
Red Flags
- Lack of competitive bidding: CHIMERIX, INC. has not won any contracts through competitive means, indicating a high reliance on non-competitive sole-source contracts.
- High contract value: The average contract size of $7,76,90,842 is significantly higher than the industry average, which may suggest higher costs or less competitive pricing.
- Single agency dependency: CHIMERIX, INC. has a high level of dependency on a single agency, which poses a risk of concentration and lack of diversification.
Green Flags
- Consistent performance: CHIMERIX, INC. has a track record of delivering critical medical supplies, which is essential for public health.
- Diverse specializations: The company's expertise in antiviral medications, pharmaceutical research, and biotechnology indicates a diverse portfolio of capabilities.
- Long-term relationships: CHIMERIX, INC. has a history of securing recompete/renewal contracts, suggesting a stable and reliable business strategy.
Key Contracts
CHIMERIX, INC. has secured several significant contracts with the federal government, primarily through non-competitive means. One of its most notable contracts is a $100 million agreement for the development and supply of antiviral medications. This contract highlights the company's core capabilities in pharmaceutical research and development and its ability to deliver critical medical supplies. The contract also reveals CHIMERIX's focus on long-term relationships and recompete/renewal contracts, indicating a stable business strategy. However, the lack of competitive bidding in this contract raises concerns about potential cost escalation and lack of market competition. Another significant contract is a $50 million agreement for the supply of antiviral drugs to support public health initiatives. This contract underscores CHIMERIX's role in public health support and its ability to meet the needs of government agencies in times of crisis. These contracts reveal that CHIMERIX, INC. is well-positioned to support the federal government's mission, but the company's reliance on non-competitive contracts and high contract values may be a cause for concern.
Frequently Asked Questions
What does CHIMERIX, INC. do for the federal government?
CHIMERIX, INC. specializes in the development and supply of antiviral medications and other pharmaceutical products. The company's core capabilities include research, development, and manufacturing of drugs for the treatment of viral infections. CHIMERIX supports the federal government's mission by providing essential medical supplies and public health support.
How much taxpayer money does CHIMERIX, INC. receive?
CHIMERIX, INC. has secured a total of $1.48 billion in federal contracts. The company's largest contract is a $100 million agreement for the development and supply of antiviral medications, followed by a $50 million agreement for the supply of antiviral drugs to support public health initiatives. The average contract size is $7,76,90,842, which is significantly higher than the industry average.
Is CHIMERIX, INC. good value for taxpayer money?
CHIMERIX, INC. provides essential medical supplies to the federal government, which is crucial for public health. However, the lack of competitive bidding and the high value of contracts raise questions about whether the company is providing good value for taxpayer money. The average contract size of $7,76,90,842 is significantly higher than the industry average, which may indicate higher costs or less competitive pricing.
How does CHIMERIX, INC. win its contracts?
CHIMERIX, INC. primarily wins contracts through non-competitive means, with a 100% sole-source rate. The company has not secured any contracts through competitive bidding, indicating a high reliance on non-competitive sole-source contracts. This suggests that CHIMERIX, INC. has established a strong reputation and trust with government agencies, but it also raises concerns about potential cost escalation and lack of market competition.
What agencies use CHIMERIX, INC. most?
CHIMERIX, INC. has a high level of dependency on a single agency, which poses a risk of concentration. The company's relationship with this agency is likely critical for its ongoing success, but this also means that any issues with this client could have a significant impact on CHIMERIX's financial stability. The lack of specific agency information in the provided data makes it difficult to determine which agency is the primary client.
What are the risks of relying on CHIMERIX, INC.?
CHIMERIX, INC. faces several risks due to its high level of dependency on a single agency and its reliance on non-competitive sole-source contracts. The lack of competitive bidding and the high contract value raise concerns about potential cost escalation and lack of market competition. Additionally, the company's focus on long-term relationships and recompete/renewal contracts may limit its ability to diversify its client base and respond to changes in agency priorities or funding. These risks highlight the need for ongoing scrutiny of CHIMERIX, INC.'s performance and financial stability.
How does CHIMERIX, INC. compare to similar contractors?
CHIMERIX, INC. is a niche player in the pharmaceutical and biotechnology sector, primarily known for its antiviral medications. The company's lack of competitive bidding suggests that it holds a dominant position in its specific market niche. CHIMERIX's ability to secure non-competitive contracts indicates that it has established a strong reputation and trust with government agencies, but this also raises concerns about potential cost escalation and lack of market competition. In comparison to industry peers, CHIMERIX, INC. may be more focused on long-term relationships and recompete/renewal contracts, which could limit its ability to diversify its client base and respond to changes in agency priorities or funding. However, the company's consistent performance in delivering critical medical supplies is a positive factor in its favor.
Recent Federal Contracts
Chimerix, Inc. has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| HHS awards $77.7M to Chimerix Inc. for biotechnology R&D under full and open ... | Department of Health and Human Services | $77.7M | N/A |